Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age55+
SponsorSingapore National Eye Centre

About this trial

The purpose of this research study is to evaluate a new screening procedure for the early detection and monitoring of Age-related Macular Degeneration (AMD) in community settings and community hospital settings, to identify associated risk factors, and develop personalized monitoring strategies for at-risk individuals throughout the 5 years follow up period, which will allow us to establish prevalence, natural history of progression of early AMD in the community.

Eligibility criteria

Qualifiers

Adults aged 55 years or older

No severe systemic illnesses that prevent study participation

Willing and able to undergo protocol-required procedures for both eyes

Willing and able to provide written informed consent

Disqualifiers

Systemic disorders that preclude reliable clinical examination or multimodal imaging

Poor compliance or severe mental illness that hinders participation

Persons who are unable to give informed consent

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Singapore National Eye Centre

Lead sponsor

Singapore Health Services

Collaborator